https://psychedelicspotlight.com/wp-content/uploads/2021/02/mindmed-psychedelic-spotlight.jpeg 524 997 Jill Ettinger https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jill Ettinger2021-02-12 20:45:082021-02-12 20:45:09Psychedelic Business News Spotlight: February 12, 2021
This week in Psychedelic business news: MindMed has a new partner, Mydecine closes a funding round, and the world’s first legal psilocybin cultivation facility launches.
https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-37.jpeg 720 1280 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2021-02-11 12:22:452022-06-09 19:26:54BIG NEWS on MindMed’s Clinical Trials [ Important MMED/MMEDF UPDATES You Need to Know ]
Hello Psychedelic Investors! Today, we will focus on MindMed's 2021 Investors Deck and Project Lucy & Project Layla's clinical trials updates. MindMed, ticker symbol MMED on the Canadian NEO Stock exchange, and MMEDF on the American OTC Market has updated their 2021 Investors Deck (TWICE) in this year. As a fellow MindMed geek, I did my due diligence to compare the information on both decks and there's a few clinical trial changes and a few other updates I found important to discuss. In this episode, we will discuss: Timecodes 0:00 - Intro 3:02 - MindMed's Project Lucy Updates 6:27 - MMED's18-MC And Microdosing Updates 9:00 - LSD to treat Suicide Headaches 11:04 - Phase 1 Updates 14:06 - Stats Updates 15:32 - MindMed Stock Speculation Zone Important to mention that after we shot this video, MindMed did answer our inquiry about the removed readout with "Hello - Sorry for the delay. We plan on filing the IND for Project Lucy in Q3 of 2021." I'm not sure if that means that there will be a readout in Q3 as well... I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com Video by Pressmaster from Pexels DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed #MMEDF #MindmedStock
https://psychedelicspotlight.com/wp-content/uploads/2021/02/ketamine-treatment-psychedelic-spotlight.jpg 667 1000 Jill Ettinger https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jill Ettinger2021-02-11 02:11:282021-02-11 02:11:30Study: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine Therapy
A new study links ketamine therapy to a significant reduction in thoughts of suicide for 69 percent of study participants.
https://psychedelicspotlight.com/wp-content/uploads/2021/02/Simplecast-RECAST-ART.png 855 1200 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2021-02-10 18:30:492021-07-21 22:24:36Interview With Carlos Tanner
In this episode, Global Trac Solutions, Inc. CEO, David Flores, has the very distinct pleasure of being joined by Carlos Tanner, founder of the Ayahuasca Foundation in Iquitos, Peru.
https://psychedelicspotlight.com/wp-content/uploads/2021/02/miley-cyrus-psychedelic-spotlight-1.jpg 720 1280 Jennifer Walker-Journey https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jennifer Walker-Journey2021-02-10 00:09:222021-02-12 02:19:20Why Ayahuasca Is Miley Cyrus’ ‘Favorite’ Drug
Singer Miley Cyrus says she's not likely to do it again, but ayahuasca is one of her favorite experiences. Find out what this psychedelic did for her.
https://psychedelicspotlight.com/wp-content/uploads/2021/02/microdosing-placebo-psychedelic-spotlight.jpg 667 1000 Evan Lewis-Healey https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Evan Lewis-Healey2021-02-08 20:02:322022-01-31 20:00:50New Research Finds Significant Role of Expectations in Psychedelic Microdosing Benefits
Are the benefits of psychedelic microdosing all in our heads? A new study looks at the results compared to placebo. The results might shock you.
https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-38.jpeg 720 1280 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2021-02-06 12:22:452022-06-09 19:26:33New Psychedelic ETF (PSYK) UPDATE: What Does This Mean For MindMed, NUMI & Compass Pathways?
In our previous video, we discussed the upcoming IPO of Horizons Psychedelic ETF (PSYK). Recently, on January 27th, PSYK began trading on the Canadian NEO Stock Exchange. In this episode we are going to discuss the psychedelic ETF and what it means for MindMed, NUMI, Compass Pathways and other stocks in the psychedelic sector. We will cover a few things such as: - PSYK's fundamentals - PSYK's CEO Steve Hawkins -Is Horizons ETF actively or passively managed? - What psychedelic stocks are included in the ETF? - How often does th ETF reorganize its stock holdings? - How is the size of the individual stocks' position decided on? - Is it worth investing in PSYK now? - What will happen to MindMed (MMED/MMEDF), Numinus Wellness (NUMI), Compass Pathways (CMPS) and the other stocks once they are included? ***A quick reminder, the psychedelic sector is at a VERY early stage, and all of these companies, large-cap and small cap alike, will need to attract more funding to complete their clinical trials and bring their products to market. PSYK will however contribute to this sector as it will bring more funding to the industry as a whole, which will both help individual companies and the wider mission of treating mental health disorders. Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #PSYK #MindMed #MMED
https://psychedelicspotlight.com/wp-content/uploads/2021/02/bright-minds-psychedelic-spotlight.png 667 1000 Jill Ettinger https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jill Ettinger2021-02-05 20:42:432021-02-09 21:38:30Psychedelic Business News Spotlight: February 5, 2021
This week in psychedelic business news, Super Mario's magic mushroom gets a new use, Mindset files three patents, Bright Minds goes public, and more.
https://psychedelicspotlight.com/wp-content/uploads/2021/02/mushroom-forest-psychedelic-spotlight.jpg 667 1000 Jill Ettinger https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jill Ettinger2021-02-05 05:41:162021-02-05 05:44:152 Massachusetts Cities Have Decriminalized Psychedelics in the Last Month
Two Massachusetts cities have decriminalized psychedelics since the start of 2021. Cambridge and Somerville say the benefits outweigh the risks.
https://psychedelicspotlight.com/wp-content/uploads/2021/02/Simplecast-RECAST-ART-3.png 855 1200 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2021-02-03 19:46:502021-07-21 22:24:41Interview With Dr. Hyder A. Khoja
In this episode, Global Trac Solution's CEO, David Flores, sits down with Dr. Hyder A. Khoja to learn more about the work they're doing at Transcendent Therapeutics Inc.